Ezetimibe: One lot recalled as some bottles may contain perindopril 4 mg tablets.
See all recalls from Ezetimibe: →Recalled Product
Sivem ezetimibe 10 mg tablets
✅ What Should You Do?
- 🛑 Stop using this product immediately and set it aside.
- Follow the instructions from the issuing agency (see below).
- 💰 Check if you are eligible for a refund or free replacement from the retailer or manufacturer.
- 📋 Report an adverse reaction to Health Canada MedEffect
Looking for a safe alternative?
Search Amazon Canada for Sivem ezetimibe 10 mg →
Hazard / Issue
Product safety
Issued by
Drugs and health products
⚠️ What You Should Do
Check your medication bottle to ensure it only contains Sivem ezetimibe 10 mg tablets.Sivem ezetimibe 10 mg is a white oblong tablet, with “93" stamped on one side and "A11" on the other.Perindopril 4 mg is a spotted light green oblong tablet, with “4” stamped on one side and nothing stamped on the other. The tablet is scored (indented) on both middle edges.If the bottle contains any unusual tablets, or if you are unsure, return it to your pharmacy immediately. Your pharmacist will check the tablets and provide you with a replacement, if needed.If you are unable to return your tablets to the pharmacy right away, talk to your pharmacist or doctor for further guidance.Seek immediate medical attention if you are experiencing serious side effects (e.g., dizziness, light-headedness or fainting, or severe allergic reaction).If you have questions about this recall, contact Sivem Pharmaceuticals by calling 1-855-757-4836 or by emailing drugsafety@mckesson.ca.Report any health product-related side effects or complaints to Health Canada.
⚖️ Were You Affected?
If you were injured or suffered a loss due to this recalled product, you may have legal options.
Search for Class Action Lawyers →Consumer Recalls Canada is not a law firm and does not provide legal advice. We may receive a referral fee if you inquire. We are not affiliated with any law firm or legal service.
Get Canada's next recall alert before it hits the news.
Free. Weekly digest or instant alerts. Unsubscribe anytime.
CASL compliant · No spam · Unsubscribe anytime